US FTC's claims for monetary relief against Vyera dismissed in Daraprim case
MLex Summary: The US Federal Trade Commission cannot bring claims seeking money damages against Vyera Pharmaceuticals and former executives over the drug Daraprim, according to a federal judge. US District Judge...To view the full article, register now.
Already a subscriber? Click here to view full article